Cellectar Biosciences, Inc. — Director's Dealing 2021

Jul 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2021-06-30

Reporting Person: NEIS JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-30	Stock option (right to buy)	$1.19	A	78000	Acquired	2031-06-30	Common Stock (78000)	Direct

Footnotes

F1: This option shall vest on the first anniversary of the date of grant.